KRAS and pancreatic neoplasm: In this study, we show that FAK expressed in kras mutant murine pancreatic cancer cells regulates the expression of IL6, which acts to amplify IL4-dependent expression of the immune checkpoint ligand PD-L2 within the PDAC TME (Fig. 6).